Immunocytochemistry and in situ hybridisation of epidermal growth factor receptor and relation to prognostic factors in breast cancer
- 1 May 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (6-7) , 1033-1037
- https://doi.org/10.1016/0959-8049(92)90449-c
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroupBritish Journal of Cancer, 1991
- Epidermal growth factor receptor and oestrogen receptors in the non-malignant part of the cancerous breastBritish Journal of Cancer, 1989
- Prognostic value of epidermal growth factor receptor in node-positive breast cancerBreast Cancer Research and Treatment, 1989
- Immunohistochemical studies on oncogene products (c-erbB-2, EGFR, c-myc) and estrogen receptor in benign and malignant breast lesionsVirchows Archiv, 1989
- Localization of immunoreactive epidermal growth factor receptors in human nervous system.Journal of Histochemistry & Cytochemistry, 1988
- Response to tamoxifen in estrogen receptor‐poor metastatic breast cancerCancer, 1987
- Monoclonal Antibodies to Human Progesterone Receptor: Characterization by Biochemical and Immunohistochemical Techniques*Endocrinology, 1987
- Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequencesNature, 1984
- Epidermal Growth FactorAnnual Review of Biochemistry, 1979
- Histological Grading and Prognosis in Breast CancerBritish Journal of Cancer, 1957